Lisa Costelloe
Dublin, L, Ireland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Elevated expression of the NLRP3 inflammasome in post-mortem brain white matter and immune cells in multiple sclerosis.
Journal: Multiple sclerosis and related disorders
Published: December 08, 2025
Downregulation of dual-specificity phosphatase 1 (DUSP1) in post-mortem brain white matter in progressive multiple sclerosis.
Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
Published: July 22, 2025
Increased Prevalence of Nitrous Oxide-Induced Subacute Combined Degeneration of the Spinal Cord: Clinical and Imaging Findings.
Journal: AJNR. American journal of neuroradiology
Published: June 03, 2025
The NLRP3 inflammasome: A central player in multiple sclerosis.
Journal: Biochemical pharmacology
Published: September 13, 2024
Botanically-Derived Δ9-Tetrahydrocannabinol and Cannabidiol, and Their 1:1 Combination, Modulate Toll-like Receptor 3 and 4 Signalling in Immune Cells from People with Multiple Sclerosis.
Journal: Molecules (Basel, Switzerland)
Published: January 21, 2022
Phytocannabinoid-dependent mTORC1 regulation is dependent upon inositol polyphosphate multikinase activity.
Journal: British journal of pharmacology
Published: July 29, 2020
Longitudinally extensive transverse myelitis after Campylobacter jejuni enteritis.
Journal: Practical neurology
Published: December 05, 2017
Alemtuzumab treatment of multiple sclerosis: long-term safety and efficacy.
Journal: Journal of neurology, neurosurgery, and psychiatry
Published: May 23, 2014
Secondary autoimmune diseases following alemtuzumab therapy for multiple sclerosis.
Journal: Expert review of neurotherapeutics
Published: February 28, 2012
Showing 1-10 of 10
Last Updated: 09/26/2026